Journal of Commercial Biotechnology — July 2008

The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and was guest-edited by Leyland Pitt and Ian McCarthy. The links below will take you to the abstract of each article:

Volume 14, Issue 3
Editorial
Leyland Pitt and Ian McCarthy

New pharmaceutical product development: Barriers to overcome and opportunities to exploit
Nic S Terblanche

The biotechnology and marketing interface: Functional integration using mechanistic and holographic responses to environmental turbulence
Pierre Berthon, Leyland Pitt, Deon Nel, Esmail Salehi-Sangari and Anne Engstrom

Anticipating and managing the challenges of biotechnology marketing
Heidi Rajamäki

A comparison of R&D indicators for the Vancouver biotechnology cluster
Monica Salazar, Martin J Bliemel and J Adam Holbrook

Using brand personality to assess whether biotechnology firms are saying the right things to their network
Lisa Papania, Colin Campbell, Robert Ankomah Opoku, Maria Styven and Jean-Paul Berthon

Remembering Epimetheus: Biotechnologies and the market
Pierre Berthon, Ekin Pehlivan and Philip DesAutels

Networks of dedicated biotechnology and service firms in Vancouver
Martin J Bliemel and Ian P McCarthy

The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb.

Share this page

Tagged as: Journal of Commercial Biotechnology